Table 2.
Agent | Given per cent (N) | Not given per cent (N) | Data missing per cent (N) |
---|---|---|---|
Chemotherapy in cohort overall | 60% (133) | 40% (88) | |
5-FU | 70% (93) | 0.7% (1) | 29.3% (39) |
Oxaliplatin + 5FU | 33%* (44) | 34% (45) | 33% (44) |
Irinotecan | 0% | 77.4% (103) | 22.6% (30) |
All those who had oxaliplatin also had 5-FU.